drugset / Trial / NCT05990374

Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years

NCT05990374

RandomizedParallel-groupTriple-blindTreatment

Summary

The efficacy of long-term treatment with different GLP-1RA (Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc.) was evaluated through 1-4 years of follow-up, and the effects of long-term treatment on blood glucose and body fat of patients.

Timeline

Start
2023-08-01
Primary completion
2024-01-01
Completion
2024-01-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Duragtide Unknown Subcutaneous
Comparator Semaglutide Peptide Subcutaneous
Comparator Tirzepatide Peptide Subcutaneous
Comparator ebenatide Peptide Subcutaneous
Comparator losenatide Unknown Subcutaneous